Hikal inks 10-year multi-product deal with global pharma co for APIs
- Country:
- India
Life sciences firm Hikal Ltd on Wednesday said it has signed a 10-year deal with a global pharmaceutical company for development and supply of a portfolio of niche Active Pharmaceutical Ingredients (APIs).
The company has signed a multi-year contract with a leading global pharmaceutical company. This contract entails the development and supply of a portfolio of niche APIs over a period of 10 years, Hikal said in a regulatory filing.
The company did not reveal the name of the global pharmaceutical firm and the value of the deal.
Hikal said the company and its customer will partner to set up a manufacturing facility to maintain security of supplies for the next 10 years.
Both the companies will jointly invest at its Panoli site in Gujarat to set up a multi-purpose manufacturing asset for manufacturing of these APIs.
Commercial supplies will commence post successful development and plant commercialisation estimated to be in FY 2024 onwards, the company added.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
- READ MORE ON:
- Hikal Ltd
- Gujarat
- Panoli
- Hikal
- Active Pharmaceutical Ingredients
ALSO READ
Cong, AAP eye tribal LS seats in Gujarat; BJP’s grip too strong, say political analysts
Gujarat govt declares May 7 voting day as public holiday
LS Polls Now Focused on Development Rather Than Caste-Religion Agenda, Says Gujarat CM
Gujarat BJP demands action against those responsible for circulating outdated video of Minister Mandaviya being attacked with a shoe
Over 20.3 lakh invitation cards to be sent across 13,000 polling stations in state: CEO Gujarat